Nucleic Acid Therapeutics
Q1 Journal
Journal
Country
United States
Northern America
Subject Area and Category
Biochemistry, Genetics and Molecular Biology
└
Biochemistry
Q1
└
Drug Discovery
Q1
└
Genetics
Q1
Publisher
SJR 2025
1.950
Q1
SJR Score
H-Index
85
Citations / Doc (2yr)
5.16
Total Docs. (latest)
32
Total Citations (3yr)
629
Publication type
Journals
ISSN
21593345, 21593337
Coverage
2011-2025
Journal Rank
#1,521
Subject Categories
Biochemistry
Q1
Drug Discovery
Q1
Genetics
Q1
Molecular Biology
Q1
Molecular Medicine
Q1
Subject Areas
Aims & Scope
Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression.
The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 32 |
| Total Docs. (3 years) | 109 |
| Total Refs. | 1,613 |
| Total Citations (3 years) | 629 |
| Citable Docs. (3 years) | 106 |
| Citations / Doc. (2 years) | 5.16 |
| Ref. / Doc. | 50.41 |
| % Female | 46.2% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.